T 2177/12 of 24.07.2013

European Case Law Identifier: ECLI:EP:BA:2013:T217712.20130724
Date of decision: 24 July 2013
Case number: T 2177/12
Online on: 7 October 2013
Petition for review of: -
Application number: 06751411.7
IPC class: A61M 39/02 A61M 39/04
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Power injector system for injecting contrast media into an intravenous line
Applicant name: C.R.Bard, Inc.
Opponent name: AESCULAP AG & Co. KG
Fresenius Kabi Deutschland GmbH
pfm medical ag
Board: 3.2.02
Headnote: -
Relevant legal provisions: European Patent Convention Art 68 European Patent Convention Art 101 European Patent Convention Art 105a European Patent Convention Art 107 European Patent Convention Art 112(1)European Patent Convention Art 113(2)Rules of procedure of the Boards of Appeal Art 16(1)(e)European Patent Convention R 71(3)European Patent Convention R 91
Keywords: Adversely affected (no)
Admissibility of the appeal (no)
Referral to Enlarged Board (no)
Apportionment of costs (no)
Catchword: -
Cited cases: G 0009/93 T 0329/88 T 0961/00 T 0655/01
Citing cases: T 0220/12 T 0964/14 T 0796/15

ORDER

For these reasons it is decided that:

1. The appeal is rejected as inadmissible.

2. The request to refer questions to the Enlarged Board of Appeal is rejected.

3. The requests for apportionment of costs are rejected.